Trupanion, Inc. (LON:0LH0)
| Market Cap | 1.07B -15.4% |
| Revenue (ttm) | 1.17B +11.4% |
| Net Income | 20.05M +72.2% |
| EPS | 0.46 +69.2% |
| Shares Out | n/a |
| PE Ratio | 54.28 |
| Forward PE | 8.40 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 9 |
| Open | 35.79 |
| Previous Close | 35.28 |
| Day's Range | 32.94 - 35.79 |
| 52-Week Range | 21.22 - 40.00 |
| Beta | 1.30 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 5, 2026 |
About Trupanion
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. and changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington. [Read more]
News
Trupanion price target raised to $33 from $30 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Trupanion (TRUP) to $33 from $30 and keeps a Neutral rating on the shares.
Trupanion price target raised to $34 from $29 at Stifel
Stifel raised the firm’s price target on Trupanion (TRUP) to $34 from $29 and keeps a Hold rating on the shares.
Trupanion price target raised to $48 from $42 at BofA
BofA raised the firm’s price target on Trupanion (TRUP) to $48 from $42 and keeps a Buy rating on the shares. The firm views the company’s Q3 report as strong.
Trupanion registers to sell 3.64M shares of common stock for holders
This filing relates to the offer and sale from time to time by the selling stockholders of up to 3.64M shares of common stock. The company is not selling any…
Trupanion reports Q3 EPS 21c, consensus 16c
Reports Q3 revenue $405.6M, consensus $402.53M. “Our third-quarter results were strong, with record cash flow and increased profitability, the seventh consecutive quarter of improvement in retention, ...
Trupanion Earnings Call Transcript: Q3 2026
Q3 revenue rose 11% YoY, while record AOI of $47 million and record free cash flow of $28.5 million supported growth investment and share repurchases. FY2026 AOI guidance was raised to $179-$182 million.
Trupanion Earnings release: Q3 2026
Trupanion released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Trupanion Prepared remarks: Q3 2026
Trupanion filed a regulatory document on November 5, 2026 disclosing important business information.
Trupanion Quarterly report: Q3 2026
Trupanion has published its Q3 2026 quarterly earnings report on November 5, 2026.
Trupanion Reports Third Quarter 2026 Results
SEATTLE, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended Sep...
Trupanion Announces Third Quarter 2026 Earnings Release and Conference Call
SEATTLE, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2026 third quarter ...
Picture Purrfect Pets: Trupanion Announces 2026 truFame Winners
SEATTLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prepare to be mesmerized by Mesmerize. To fall in love with Friday.
Trupanion price target lowered to $30 from $34 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Trupanion (TRUP) to $30 from $34 and keeps a Neutral rating on the shares. The firm previewed Q3 earnings for the P&C…
Trupanion Searches for this Year's “It Pets” With Return of Annual truFame Contest
SEATTLE, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The search is on for Trupanion's next four-legged stars.
Trupanion downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler downgraded Trupanion (TRUP) to Neutral from Overweight with a price target of $32, down from $45. The firm says the company is “facing a dual-threat macro environment” due…
Trupanion price target raised to $29 from $28 at Stifel
Stifel raised the firm’s price target on Trupanion (TRUP) to $29 from $28 and keeps a Hold rating on the shares. The company’s consistent rate of share loss is of…
Trupanion Partners with Home To Home® to Help More Pets Transition Directly from One Loving Home to Another
SEATTLE, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Every pet deserves the opportunity to live a happy, healthy life in a loving home. But when life takes an unexpected turn, some families are faced with the h...
Trupanion reports Q2 EPS 16c vs. 22c last year
Reports Q2 revenue $392.93M, consensus $389.72M. “We continue to execute on the priorities that matter most by growing margin, improving the economics of new enrollments, and investing our capital wit...
Trupanion announces $100M stock repurchase program
The board has authorized a share repurchase program, pursuant to which the company may repurchase up to an aggregate of $100M of its outstanding shares of common stock, with no…
Trupanion Earnings Call Transcript: Q2 2026
Q2 saw 24% growth in adjusted operating income, strong pet adds, and improved retention. Revenue and free cash flow rose year-over-year, with a $100 million share repurchase program announced. Guidance for 2026 was raised, reflecting confidence in continued growth.
Trupanion Earnings release: Q2 2026
Trupanion released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
Trupanion Quarterly report: Q2 2026
Trupanion has published its Q2 2026 quarterly earnings report on August 5, 2026.
Trupanion Slides: Q2 2026
Trupanion has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
Trupanion Reports Second Quarter 2026 Results
SEATTLE, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended Jun...
Less Paperwork. More Pets.
SEATTLE, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Every minute matters in a veterinary hospital. But too often, valuable time is spent navigating paperwork and answering payment questions instead of focusing...